Do higher BNP/NT-proBNP levels predict adverse long-term outcomes in patients with and without heart failure?
BNP and NT-proBNP are useful prognostic biomarkers for adverse long-term outcomes regardless of a prior heart failure diagnosis.
BNP/NT-proBNP levels are predictors for adverse long-term outcome in patients with and without known heart failure. Further research is necessary to establish appropriate thresholds, especially in non-heart failure cohorts.
Hendricks et al. (Wed,) studied this question.